Impact of <i>TRAF3IP2</i>, <i>IL10</i> and <i>HCP5</i> Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis

Impact of <i>TRAF3IP2</i>, <i>IL10</i> and <i>HCP5</i> Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis

Psoriatic arthritis (PsA) is a chronic inflammatory rheumatic disease. The introduction of therapy with biological drugs is promising, even if the efficacy is very variable. Since the response to drugs is a complex trait, identifying genetic factors associated to treatment response could help define...

Full description

Bibliographic Details
Main Authors: Giada De Benedittis, Andrea Latini, Cinzia Ciccacci, Paola Conigliaro, Paola Triggianese, Mauro Fatica, Lucia Novelli, Maria Sole Chimenti, Paola Borgiani
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Personalized Medicine
Subjects:
psoriatic arthritis
polymorphisms
treatment
TNF-i
Online Access:https://www.mdpi.com/2075-4426/12/7/1094

Internet

https://www.mdpi.com/2075-4426/12/7/1094

Similar Items